The Gavi Alliance Board, at its meeting in November 2017, approved continued Gavi Alliance engagement with all countries after they have transitioned from Gavi support. The goal of this engagement is to ensure that these countries sustain the gains achieved with Gavi support and mitigate potential risks to the sustainability of now self-financed vaccine programs. Any country that has or will have transitioned from Gavi support by the end of 2019 is eligible to apply for post-transition engagement support,

The LNCT webinar, ‘Ask Gavi Session 1: Q&A on Post-Transition Country Support,’ took place on 29 November 2018. The discussion focused on Gavi post-transition country support requests. Panelists included Joanna Wisniewska, IF&S Senior Program Manager who reviewed the post-transition support process and provided an update on country support requests. Mr. Alexei Ceban, National Agency for Public Health,

Through a review of available literature on the subject, this study, conducted by WHO, documents the lack of comparative analyses on immunization system performance in countries transitioning from Gavi support. Despite increased emphasis on the importance of programmatic sustainability beyond financing through the Gavi 2016–2020 Strategy and availability of data, existing literature has predominantly documented challenges related to domestic financing of immunization.

The LNCT webinar, ‘Vaccine Prices for Countries After Gavi Transition,’ took place on 17 July 2018. The webinar materials were presented by Juliette Puret, Senior Program Manager, Immunization Financing and Sustainability, Gavi. Included here are the presentation materials used for the webinar.

Session Slides: English | Français | Portugués | русский

Projected Health Financing Transitions: Timeline and Magnitude, a new working paper that was recently released, maps out an indicative timeline of transition, along with the fiscal impact, through 2040 across five global health financing mechanisms, including Gavi, the Vaccine Alliance. Research findings from the paper show that:

• By 2040, Gavi will see major transformations of its funding portfolios
• Countries in the most fiscal jeopardy from anticipated transition are not those transitioning based on GDP per capita or disease burden,

This website serves as a central hub for accessing information on immunization programs within countries, Gavi’s policies, and key articles or from partner organizations. You can also explore immunization coverage data and news announcements for each Gavi country.